Purpose: Opioids are concerned as a major cause of postoperative respiratory depression. In the immediate postoperative period, however, other factors can produce instability of breathing such as pain, agitation, and residual effects of anesthetics. Such factors might be overlooked masked by the fear for opioid-induced respiratory depression. We report a case who presented apnea immediately after emergence from anesthesia that we considered was produced by an interaction among such factors accompanied with fentanyl-induced respiratory depression. Clinical Features: A 31-year-old woman underwent ovarian cystectomy under general anesthesia with continuous infusions of propofol and remifentanil, and bolus doses of fentanyl. Transversus abdominis plane blocks with ropivacaine were given upon completion of surgery. She complained of severe wound pain and was agitated at the emergence from anesthesia. Fentanyl 50 µg was administered intravenously. In several minutes, she developed apnea, unconsciousness, and difficulty of mechanical ventilation via a face mask. The estimated effect site concentration at the onset of the episode (2.9 ng•ml −1 ) was approximately the same (3.0 ng•ml −1 ) as after 30 min when she regained consciousness and spontaneous breathing. It indicated that not only direct inhibition of the respiratory center by fentanyl but also other stimulatory and inhibitory factors contributed to respiratory arrest. Conclusion: In the immediate postoperative period, transient factors, such as pain, mental instability and anesthetic residues, which are indirectly-related with breathing, can interact each other and with opioids. The interaction would induce apnea through mechanisms combined among direct inhibition of the respiratory center, and modulation of chemical and cortical controls of breathing.
Introduction
Opioids are feared as inducing postoperative respiratory depression [1] [2] . However, breathing is generated in the brain stem respiratory center, and modulated through largely a combination of chemical, reflex, and cortical control mechanisms. We present here a case agonized by respiratory arrest occurring at the immediate postoperative period. The apnea was considered produced not solely due to opioids but by a multitude of factors, either inhibitory or stimulatory to breathing, interrelating with one another. The factors include chemical and cortical controls of breathing, pain, and respiratory mechanics as well as inhibition of the respiratory center by fentanyl. This report emphasizes the importance of comprehensive knowledge of the respiratory effect of opioids, and other factors that can affect chemical and cortical controls of breathing.
Written consent for publication of this case was obtained from the patient. The Institutional Review Board of Tokyo Women's Medical University declared the study exempt from approval.
Case Report
A 31-year-old woman (163 cm, 54 kg) was scheduled for resection of an ovarian cyst. Preoperative routine examinations revealed no abnormalities. She had no history of allergies. At the preoperative visit, she expressed extraneous concerns about postoperative pain seemingly beyond the extent of normal preoperative anxiety. General anesthesia combined with epidural anesthesia was planned. We, however, were forced to halt epidural catheterization due to her intolerance to the procedure despite a prior intravenous (i.v.) administration of 100 µg fentanyl and an affable conduct. General anesthesia was induced with remifentanil 0.5 µg•kg ) was initiated instantaneously. It, however, was inefficient, and oxygen saturation dropped to approximately 60%. Supplementation of sevoflurane 5% into the inspired gas gradually ameliorated ventilation difficulty, restoring oxygen saturation to 98%. She regained consciousness and spontaneous breathing 30 min later and complained again of moderate wound pain. Additional four aliquot doses of i.v. fentanyl 25 µg each in 20 min, and a rectal acetaminophen 300 mg did not alleviate pain, and therefore we performed a wound infiltration of ropivacaine 120 mg.
In the ward, IV-PCA was continued for 48 h postoperatively. The patient self-administered rescue doses 12 times for the first 12 h. Oral loxoprofen 180 mg•day −1 was started on the postoperative day 3, and pain gradually subsided. Otherwise, she experienced an uneventful postoperative course and discharged from the hospital on the postoperative day 7.
The concentrations of propofol, remifentanil, and fentanyl in the effect sites and in plasma were estimated using pharmacokinetic and pharmacodynamic models developed by Mash for propofol, by Minto for remifentanil, and by Shafer for fentanyl, respectively. (TIVA Trainer © version 9, Eurosiva, The Netherlands). The results were presented in Figure 1 .
Discussion
An amount of fentanyl 50 µg, administered at the emergence from anesthesia was perhaps insufficient as a sole cause of apnea induced by depressing the activity of the respiratory center. Indeed, the estimated effect site concentration of fentanyl at the onset of apnea (2.9 ng•ml −1 ) was approximately the same as that at regaining spontaneous breathing and consciousness (3.0 ng•ml −1 ) (Figure 1) . Therefore, it is likely that a multitude of factors, either concerting or conflicting, intertwined complexly one another, producing respiratory arrest as schematized in Figure 2 . Plausible mechanisms responsible for the apnea that we consider are: 1) an excitation of the respiratory center by pain and instabilities in mentality and emotions, and contrarily an inhibition of the respiratory center by fentanyl; 2) a reduction of pain-augmented respiratory drive by fentanyl and TAP blocks; 3) hyperventilation by emotional distress and pain leading to hypocapnia, and a blunted ventilatory response to carbon dioxide by fentanyl; 4) respiratory depression due to residual narcosis by propofol; and 5) glottic closure induced by fentanyl. Considering the marginal concentrations estimated of remifentanil both in the effect site and in plasma, the effect of remifentanil would be negligible.
At the emergence from anesthesia, the patient was agitated and complained of severe wound pain. Emotional upset stimulates the respiratory center [3] . Pain works itself as a respiratory stimulant [4] by acting both on the respiratory center [5] and on the central chemoreceptors [6] . Both emotional disruption and pain aggravate each other [7] , further stimulating breathing and thus leading to a vicious spiral of hyperventilation. On the other hand, respiratory inhibitions, though each small, by residues of propofol and fentanyl administered during anesthesia [8] might still remain at the period. It is, therefore, likely that the patient's breathing was maintained on a delicate balance between stimulatory and inhibitory effects of these factors.
It is possible that two analgesic regimens, TAP blocks and i.v. 50 µg fentanyl, at the emergence from anesthesia disrupted the balance, resulting in apnea. The TAP blocks reduced wound pain, possibly diminishing pain-augmented respiratory drive. Indeed, several studies and case reports indicated an important role of pain in the maintenance of breathing. Combes et al. [9] demonstrated in patients treated postoperative pain by i.v. morphine that complete pain resolution by supplemental peripheral nerve block worsened respiratory depression. In patients medicated large doses of slow-release opioids without successful relief of cancer or chronic pain, spinal cordotomy or epidural analgesia produced life-threatening respiratory arrest [10] - [12] .These studies suggest that unrelieved pain offsets opioid-induced respiratory depression, thus helping barely keep respiratory drive. It was indicated that complete resolution of pain attained by spinal cordotomy or epidural analgesia diminished painstimulated respiratory drive.
Furthermore, the 50 µg fentanyl administered immediately after the emergence from anesthesia decreased pain intensity, awareness, and emotional instability, that would reduce in an interactive manner those respiratory stimulating effects [5] [6] [8] [13] [14] . In addition to a direct inhibition of the respiratory center, chemoreceptor depression by the 50 µg fentanyl would be enhanced under the hyperventilation-induced hypocapnia, more likely inducing apnea (Figure 3) [15] . Besides, we experienced a difficulty in mechanical ventilation via a face mask at the onset of apnea. It indicated that opioid-induced laryngeal closure might take some role in the respiratory arrest [16] - [19] . The aforementioned mechanisms are only speculative, and we are unable to propose explicit mechanisms that produced apnea in the patient. We, therefore, may need to consider technical misconducts that could have precipitated the patient's breathing condition. Residual remifentanil still existing in the venous route could have caused apnea. It was, however, unlikely because the remifentanil infusion was terminated with the syringe unhitched more than 30 min before the apneic episode. Accidental retrograde infusion of remifentanil into the i.v. fluid bag would be another possibility. It is also negated since a one-way valve was in place between the syringe line and the i.v. fluid bag.
We might lack a thoughtful anesthesia management. First, the patient revealed apnea some 30 min after TAP blocks and at the emergence from anesthesia. Griffiths et al. [20] reported that 3 mg•kg −1 of ropivacaine administered by TAP blocks in adult female patients resulted in potentially toxic plasma concentrations with the peak concentration occurring 30 min post-injection. Latzke et al. [21] demonstrated that a time to the maximum concentration of plasma ropivaine was 0.44 ± 0.36 h (mean ± SD) after injection in 8 healthy volunteers administered 150 mg ropivacaine by TAP block. However, neither signs of neurotoxicity [22] nor cardiovascular instability were detected in our case. It indicates that the central effect of ropivacaine on the respiratory depression, even if it existed, would be negligible. Though, we might better administer TAP blocks preoperatively. Second, we administered bolus doses of fentanyl while applying a continuous infusion of remifentanil. We intended to use fentanyl for a smooth transition from remifentanil for anesthesia to postoperative IV-PCA fentanyl. However, a short duration of the surgery (62 min) made us to administer fentanyl in the midst of remifentanil infusion. Third, high preoperative anxiety was shown to be negatively associated with recovery from anesthesia and control of postoperative pain [23] . A use of anxiolytics in addition to analgesics might be an appropriate choice at the emergence from anesthesia since the patient could be expected to be susceptible to postoperative agitation, considering her fragile mentality [24] . Fourth, an insufflation of sevoflurane in an attempt to relieve ventilation difficulty might be inappropriate [25] . However, we were unable to immediately prepare intravenous glottis dilators such as a muscle relaxant and propofol when we faced with the ventilation difficulty.
Conclusion
In the immediate postoperative period, transient factors such as pain, mental instability, and anesthetic residues, which are indirectly related to breathing, can interact with each other and with opioid. Such interactions can induce apnea through mechanisms combined among direct inhibition of the respiratory center, and chemical and cortical controls of breathing. This report emphasizes the importance of comprehensive knowledge of the respiratory effect of opioids, and other factors that can affect chemical and cortical controls of breathing in the postoperative pain management.
